The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in rats

Overview of attention for article published in Frontiers in Neuroscience, January 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 35 Dimensions

Readers on

mendeley: 36 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 35 publications that cite this research output.

35

The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.

Suvorexant improves mitochondrial dynamics with the regulation of orexinergic and mTOR activation in rats exhibiting PTSD-like symptoms

Article in Journal of Affective Disorders (January 2024)

Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease

Article in The Annual Review of Pharmacology and Toxicology (September 2023)

Orexin 2 receptor antagonism sex‐dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice

Article in British Journal of Pharmacology (September 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.